Treating epidermolysis bullosa with thymosin beta 4

Details Treating epidermolysis bullosa with thymosin beta 4 Treating epidermolysis bullosa with thymosin beta 4

A - Human Necessities

61

K

A61K 38/08 (2006.01) A61K 38/20 (2006.01) A61K 38/22 (2006.01) A61K 39/395 (2006.01)

Patent

CA 2446072

Blister, sores or skin degradation associated with Epidermolysis Bullosa is treated or prevented by administration of a actin-sequestering peptide such as Thymosin .beta.4, an isoform of Thymosin .beta.4 or oxidized Thymosin .beta.4.

L'invention concerne une dégradation de la peau, de plaies ou de cloques, associée à l'épidermolyse bulleuse congénitale que l'on traite ou empêche par l'administration d'une peptide sécrétrice d'actine comme la Thymosine .beta.4, un isoforme de la Thymosine .beta.4 ou de la Thymosine .beta.4 oxydée.

Affiliated with

Also associated with

Rating

Treating epidermolysis bullosa with thymosin beta 4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treating epidermolysis bullosa with thymosin beta 4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating epidermolysis bullosa with thymosin beta 4 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1436163